Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study

Ann Rheum Dis. 2018 Jul;77(7):1091-1093. doi: 10.1136/annrheumdis-2017-211313. Epub 2017 Jul 3.

¹ Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
² St George & Sutherland Clinical School, University of New South Wales, Sydney, Australia.
³ School of Medicine, University of Queensland and Royal Brisbane and Womenâ€™s Hospital, Brisbane, Australia.
⁴ School of Medicine, Swedish Medical Center and University of Washington, Seattle, Washington, USA.
⁵ Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.
⁶ Speciality Care, Pfizer, West Ryde, New South Wales, Australia.
⁷ Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania, USA.
⁸ Department of Biostatistics, inVentiv Health, Princeton, New Jersey, USA.
⁹ Department of Rheumatology, University Pierre et Marie Curie Paris 6 HÃ'pital Cochin, AP-HP, INSERM U1153 and PRES Sorbonne Paris City, Paris, France.

No abstract available

Keywords: anti-TNF; magnetic resonance imaging; spondyloarthritis; treatment.

Publication types